HIV

ViiV Healthcare Receives Chinese Approval for Long-Acting HIV Treatment Vocabria and Rekambys

(IN BRIEF) ViiV Healthcare has received approval from China's National Medical Products Administration (NMPA) for Vocabria (cabotegravir) in combination with…

6 months ago

GSK’s ViiV Healthcare to Share Latest Advances in HIV Treatment and Prevention at EACS 2023

(IN BRIEF) ViiV Healthcare, a global specialist HIV company, will present 23 abstracts at the 19th Annual European AIDS Conference…

7 months ago

Researchers urge countries to intensify efforts to eliminate HIV and HCV in high-risk populations

(IN BRIEF) New research led by the University of Bristol shows that countries need to improve their tracking of HIV…

1 year ago

University of Liverpool: Single genetic change in Salmonella plays key role in the devastating epidemic of bloodstream infections in sub-Saharan Africa

LIVERPOOL, 02-Mar-2018 — /EuropaWire/ — Scientists at the University of Liverpool have identified a single genetic change in Salmonella that is…

6 years ago

GSK and Pfizer owned ViiV Healthcare announced US regulatory submission for STR combining dolutegravir with abacavir and lamivudine for people living with HIV

London, UK, 23-10-2013 — /EuropaWire/ — ViiV Healthcare today announced the submission of a regulatory application in the United States for its…

11 years ago